OBJECTIVE	To investigate the pharmacodynamic profile and duration of action for five subcutaneous doses of insulin detemir ( 0.1 , 0.2 , 0.4 , 0.8 , and 1.6 units/kg ; 1 unit = 24 nmol ) and one subcutaneous dose of NPH insulin ( 0.3 IU/kg ; 1 IU = 6 nmol ) .\